CDKN2B and atherosclerosis: Recently, it has been hypothesized that the regulation of CDKN2B gene expression by lncANRIL could be involved in glucose homeostasis (71), while in diabetic patients, high glucose could alter ANRIL expression, favoring cell adhesion and cell proliferation, thereby leading to atherosclerosis (72).